Haleon (LON:HLN) Trading Down 1.2%

Haleon plc (LON:HLN)’s share price traded down 1.2% during trading on Thursday . The company traded as low as GBX 322.20 ($4.08) and last traded at GBX 322.20 ($4.08). 10,019,905 shares changed hands during trading, a decline of 51% from the average session volume of 20,297,662 shares. The stock had previously closed at GBX 326.10 ($4.12).

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. HSBC assumed coverage on Haleon in a research report on Thursday, April 18th. They issued a “buy” rating for the company. Barclays dropped their price objective on shares of Haleon from GBX 390 ($4.93) to GBX 383 ($4.84) and set an “overweight” rating for the company in a report on Tuesday, April 9th.

Haleon Stock Performance

The stock has a market capitalization of £29.42 billion and a PE ratio of 2,685.00. The company has a quick ratio of 0.93, a current ratio of 1.04 and a debt-to-equity ratio of 57.42. The stock has a fifty day moving average of GBX 327.74 and a 200-day moving average of GBX 326.03.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.